These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2545591)

  • 1. Carbohydrate metabolism in hepatocellular carcinoma: where does the glucose go?
    Marchesini G; Bianchi G
    Hepatology; 1989 Aug; 10(2):253-5. PubMed ID: 2545591
    [No Abstract]   [Full Text] [Related]  

  • 2. Carbohydrate metabolism in patients with primary hepatocellular carcinoma.
    Vinik AI; Pooler W
    Clin Sci Mol Med; 1973 Sep; 45(3):387-96. PubMed ID: 4361808
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on hypoglycaemia in primary carcinoma of the liver. A case report and review of pathogenetic mechanisms.
    Vinik AI; Deppe WM
    S Afr Med J; 1974 Mar; 47(12):518-24. PubMed ID: 4363729
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies of insulin and growth hormone secretion in a subject with hepatoma and gypoglycemia.
    Colwell JA; Wilber JF
    Diabetes; 1971 Sep; 20(9):607-14. PubMed ID: 4328691
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypoglycemia associated with extrapancreatic tumors. Report of two cases with studies on its pathogenesis.
    Chandalia HB; Boshell BR
    Arch Intern Med; 1972 Mar; 129(3):447-56. PubMed ID: 4336020
    [No Abstract]   [Full Text] [Related]  

  • 6. Insulin and growth hormone response to an oral glucose load in Ugandan hepatocellular carcinoma patients.
    Primack A; Kajubi S
    East Afr Med J; 1974 Aug; 51(8):574-8. PubMed ID: 4371198
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypoglycemia in a child with hepatoblastoma.
    Ha K; Ikeda T; Okada S; Inui K; Tagawa T; Takada K; Uchimura N; Kakudo K; Okada A; Yabuuchi H
    Med Pediatr Oncol; 1980; 8(4):335-41. PubMed ID: 6256618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of IGF-II producing liver hepatocellular carcinoma with hypoglycemia].
    Inoue R; Ito Y; Nishimiya M; Miyazaki S; Moriuchi A; Sakata T
    Nihon Naika Gakkai Zasshi; 1997 Jun; 86(6):1033-5. PubMed ID: 9340344
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypoglycemia, an atypical early sign of hepatocellular carcinoma.
    Sorlini M; Benini F; Cravarezza P; Romanelli G
    J Gastrointest Cancer; 2010 Sep; 41(3):209-11. PubMed ID: 20204540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Modifications of carbohydrate metabolism observed during hepatocarcinogenesis induced by DAB. I. Studies on glycogen metabolism].
    Meunier M; Jacob A
    Int J Cancer; 1968 Jul; 3(4):454-9. PubMed ID: 4300775
    [No Abstract]   [Full Text] [Related]  

  • 11. Carbohydrate changes in liver disease.
    Sherlock S
    Am J Clin Nutr; 1970 Apr; 23(4):462-6. PubMed ID: 4315010
    [No Abstract]   [Full Text] [Related]  

  • 12. Lipid accumulation in a hepatocellular carcinoma associated with hypoglycaemia.
    Chan WC; Ma L
    Pathology; 1975 Oct; 7(4):299-305. PubMed ID: 177931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Torsades de pointes associated with terfenadine in a case of liver cirrhosis and hepatocellular carcinoma.
    Kamisako T; Adachi Y; Nakagawa H; Yamamoto T
    Intern Med; 1995 Feb; 34(2):92-5. PubMed ID: 7727886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin K deficiency and hepatocellular carcinoma.
    Piquet MA; Hourmand-Ollivier I; Dao T
    JAMA; 2004 Dec; 292(21):2580-1; author reply 2581. PubMed ID: 15572713
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypoglycemia associated with lipid accumulation in primary hepatocellular carcinoma.
    Yeung RT; Yeung DC
    Cancer; 1973 Dec; 32(6):1482-89. PubMed ID: 4357080
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hypoglycemia in liver diseases].
    Zigman-Igra I
    Harefuah; 1972 May; 82(9):420-1. PubMed ID: 5041222
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatocyte AgNOR protein quantitative expression is a powerful parameter for predicting hepatocellular carcinoma development in liver cirrhosis.
    Trerè D; Borzio M; Roncalli M; Derenzini M
    Eur J Histochem; 1997; 41 Suppl 2():149-50. PubMed ID: 9859825
    [No Abstract]   [Full Text] [Related]  

  • 18. The ether lipid tumour marker in human liver with hepatocellular carcinoma.
    Lin HJ; Wu PC; Ho JC
    Br J Cancer; 1980 Feb; 41(2):320-4. PubMed ID: 6245673
    [No Abstract]   [Full Text] [Related]  

  • 19. Glucose utilization in a patient with hepatoma and hypoglycemia. Assessment by a positron emission tomography.
    Eastman RC; Carson RE; Orloff DG; Cochran CS; Perdue JF; Rechler MM; Lanau F; Roberts CT; Shapiro J; Roth J
    J Clin Invest; 1992 Jun; 89(6):1958-63. PubMed ID: 1318326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypoglycemia and primary liver cancer. Hormone levels. Action of diazoxide].
    Paraf A; Rautureau J; Benabadji A
    Rev Med Chir Mal Foie; 1967 Jun; 42(3):157-66. PubMed ID: 4313299
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.